Somewhat Positive News Coverage Somewhat Unlikely to Impact Icon Plc (ICLR) Stock Price

News coverage about Icon Plc (NASDAQ:ICLR) has been trending somewhat positive this week, Accern Sentiment reports. Accern identifies positive and negative media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Icon Plc earned a media sentiment score of 0.20 on Accern’s scale. Accern also gave press coverage about the medical research company an impact score of 46.137311612813 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Here are some of the media stories that may have impacted Accern Sentiment Analysis’s rankings:

ICLR has been the subject of several research reports. Zacks Investment Research upgraded shares of Icon Plc from a “hold” rating to a “buy” rating and set a $131.00 price objective for the company in a research report on Saturday, September 9th. Bank of America Corporation began coverage on shares of Icon Plc in a research report on Monday, September 11th. They issued a “buy” rating and a $128.00 price target for the company. ValuEngine upgraded shares of Icon Plc from a “hold” rating to a “buy” rating in a research report on Friday, September 1st. Jefferies Group LLC reiterated a “buy” rating on shares of Icon Plc in a research report on Sunday, July 30th. Finally, Credit Suisse Group reiterated an “outperform” rating and issued a $120.00 price target (up from $105.00) on shares of Icon Plc in a research report on Monday, October 16th. Four analysts have rated the stock with a hold rating, seven have issued a buy rating and two have given a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $121.00.

Icon Plc (ICLR) traded up $1.57 during midday trading on Friday, hitting $117.25. 271,277 shares of the company’s stock were exchanged, compared to its average volume of 329,146. The company has a market capitalization of $6,349.32, a PE ratio of 22.50, a PEG ratio of 1.81 and a beta of 0.56. Icon Plc has a 12-month low of $73.76 and a 12-month high of $124.48. The company has a current ratio of 1.90, a quick ratio of 1.90 and a debt-to-equity ratio of 0.31.

Icon Plc (NASDAQ:ICLR) last posted its earnings results on Thursday, October 26th. The medical research company reported $1.35 earnings per share for the quarter, topping analysts’ consensus estimates of $1.32 by $0.03. The firm had revenue of $440.30 million for the quarter, compared to analysts’ expectations of $438.09 million. Icon Plc had a net margin of 16.37% and a return on equity of 28.42%. The company’s revenue was up 4.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.19 earnings per share. analysts expect that Icon Plc will post 5.36 EPS for the current year.

ILLEGAL ACTIVITY WARNING: “Somewhat Positive News Coverage Somewhat Unlikely to Impact Icon Plc (ICLR) Stock Price” was first reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this story on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be viewed at

About Icon Plc

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies.

Insider Buying and Selling by Quarter for Icon Plc (NASDAQ:ICLR)

Receive News & Ratings for Icon Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icon Plc and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply